Table 2. Incidence of VTE in MM trials... | American Society of Hematology

Table 2.

Incidence of VTE in MM trials using thalidomide or lenalidomide with thromboprophylaxis

Incidence of VTE in MM trials using thalidomide or lenalidomide with thromboprophylaxis

Incidence of VTE in MM trials using thalidomide or lenalidomide with thromboprophylaxis

This Feature Is Available To Subscribers Only

Sign In or Create an Account